WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.
https://www.wavelifesciences.com/© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd diotorisasi dan diatur oleh Komisi Sekuritas dan Bursa Siprus sesuai dengan lisensi No.281/15 yang dikeluarkan pada 25/09/2015. Trademark "Just2Trade" dimiliki oleh LimeTrading (CY) Ltd.
Nomor Registrasi: HE 341520
Alamat: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Penafian:
Semua promosi, materi, dan informasi situs web ini mungkin memiliki ketentuan yang berlaku. Silakan hubungi Perusahaan untuk keterangan lebih lanjut
Trading di pasar keuangan mengandung risiko. Nilai investasi bisa naik atau turun, dan investor bisa kehilangan semua modal investasinya. Dalam hal produk dengan leverage, nilai kerugian mungkin saja lebih besar dibandingkan modal awal investasi. Informasi terperinci tentang risiko terkait dengan trading di pasar keuangan dapat ditemukan di Syarat dan Ketentuan Umum untuk Penyediaan Layanan Investasi.
E-mail: 24_support@just2trade.online
